Key result
Continuous ECG monitoring detects recurrent AF in ~11% of patients after cardiac surgery.
Why the study?
New-onset postoperative atrial fibrillation complicates 30% of cardiac surgeries, and structured follow-up may identify patients with recurrent AF who benefit from evidence-based therapies.
Cohort (n=881)
No
Approximately 1 in 10 patients with new-onset POAF following cardiac surgery will experience AF recurrence within 2-3 months, highlighting the potential value of structured ambulatory ECG follow-up to identify patients needing ongoing anticoagulation.
Answers are grounded in this paper and cite their sources.
May support targeted ambulatory monitoring after cardiac surgery POAF; leaves open whether it alters anticoagulation decisions or outcomes.
Background: New-onset postoperative atrial fibrillation (POAF) complicates 30% of cardiac surgeries. Although POAF is often transient, structured follow-up care of patients with POAF may identify those with paroxysmal or persistent atrial fibrillation (AF) who will benefit from evidence-based therapies. Methods: This retrospective study includes patients seen in a clinic dedicated to patients with POAF after cardiac surgery between 2020 and 2024. Per the clinic's operating procedure, patients wore a 14-day continuous ambulatory electrocardiogram (ECG) monitor fpr 2 months after surgery and were assessed thereafter in clinic. The primary outcome was recurrent AF lasting ≥ 30 seconds, captured by 14-day continuous ambulatory ECG or during clinical care. At discharge, 798 patients (90.6%) were prescribed amiodarone, and 435 (49.4%) were prescribed oral anticoagulation. The mean time between discharge and 14-day continuous ambulatory ECG monitor was 72 days (IQR 61-84). AF recurrence was detected in 94 patients (10.7%); 30 patients (36.1%) were not receiving oral anticoagulation at the time of recurrence. Among patients with recurrence detected by 14-day continuous ambulatory ECG, the median duration was 10 hours (IQR 2-253). Left atrial volume index was the only independent predictor of AF recurrence. Following the clinic visit, oral anticoagulation was continued in 122 patients (28.2%). Conclusions: Among patients with POAF following cardiac surgery, 1 in 10 have AF recurrence, as determined by a structured 14-day continuous ambulatory ECG monitor utilized 2-3 months postoperatively.
No takes yet. Share an insight, caveat, or question.
Suri et al. (2025) conducted a cohort in New-onset postoperative atrial fibrillation (POAF) after cardiac surgery (n=881). New-onset postoperative atrial fibrillation (POAF) was evaluated on Recurrent atrial fibrillation lasting ≥ 30 seconds. Among patients with new-onset postoperative atrial fibrillation after cardiac surgery, 10.7% experienced recurrence when monitored with a 14-day continuous ambulatory ECG at 2-3 months.
Synapse has enriched 10 related papers. Consider them for comparative context: